5-(4-phenylbutoxy)psoralen has been researched along with Leukemia--Lymphocytic--Chronic--B-Cell* in 1 studies
1 other study(ies) available for 5-(4-phenylbutoxy)psoralen and Leukemia--Lymphocytic--Chronic--B-Cell
| Article | Year |
|---|---|
Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia.
Topics: Clofazimine; Ficusin; Humans; Kv1.3 Potassium Channel; Leukemia, Lymphocytic, Chronic, B-Cell; Pancreatitis-Associated Proteins; Potassium Channel Blockers | 2013 |